Skip to content

Michael B. Gatch

23 papers in the library · 501 citations · publishing 2009-2026

Papers

Sort Most recent Most cited

Locomotor and discriminative stimulus effects of N-cyclohexyl butylone and N-cyclohexyl methylone.

Frontiers in Pharmacology 2026 Michael B. Gatch, Shuping Jia, Ritu A. Shetty et al.

N-Cyclohexyl butylone and N-cyclohexyl methylone are cathinones found on the street that produce morbidity and mortality, but are not yet legally controlled, and there has been little or no pharmacological testing of these compounds. Both compounds have a large moiety on the N-position that may alter their pharmacological effects. Locomotor stimulant effects of N-cyclohexyl butylone and...

Behavioral effects of three synthetic tryptamine derivatives in rodents.

Journal of Psychopharmacology April 4, 2025 Rebecca D. Hill, Ritu A. Shetty, Nathalie Sumien et al.

New synthetic tryptamine derivatives have emerged in the underground market. They act on serotonin receptors mimicking the effects of hallucinogenic drugs such as DOM. The DEA has identified three tryptamine derivatives of concern, 5-MeO-DBT, 5-Cl-DMT, and 4-OH-MiPT. Swiss Webster mice were tested for locomotor activity. Discriminative stimulus effects were tested in male Sprague-Dawley rats...

DOI: 10.1177/02698811251330737 (opens in new tab) Full text (opens in new tab) Serotonin Drug discrimination Hallucinogens psychedelics Entheogens +4

Locomotor and discriminative stimulus effects of NBOH hallucinogens in rodents.

Behavioural Pharmacology December 6, 2024 Daaniyal D. Munir, Ritu A. Shetty, Michael B. Gatch et al. 1 citation

Despite the efforts of the Drug Enforcement Administration to safeguard the public from hazardous analogs of synthetic hallucinogens, these compounds have increasingly been observed in the illicit drug market. Four novel compounds were found to be similar in structure to the previously described 25X-NBOMe synthetic hallucinogens. These four compounds, 25B-NBOH, 25C-NBOH, 25E-NBOH, and 25I-NBOH...

DOI: 10.1097/fbp.0000000000000802 (opens in new tab) Full text (opens in new tab) Nbohs Emerging compounds Novel psychoactive substances Synthetic hallucinogens +12

Locomotor and discriminative stimulus effects of three benzofuran compounds in comparison to abused psychostimulants

Drug and Alcohol Dependence Reports August 10, 2023 Rebecca D. Hill, Ritu A. Shetty, Nathalie Sumien et al. 4 citations

Aims: Benzofurans are used recreationally, due their ability to cause psychostimulant and/or entactogenic effects, but unfortunately produce substantial adverse effects, including death. Three benzofurans 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-APDB), 5-(2-aminopropyl)-2,3-dihydrobenzofuran (5-MAPB) and 6-(2-aminopropyl) benzofuran (6-APB) were tested to determine their behavioral effects in...

Discriminative Stimulus Effects of Substituted Tryptamines in Rats

ACS Pharmacology & Translational Science December 29, 2020 Michael B. Gatch, Adam C. Hoch, Theresa M. Carbonaro 13 citations

Novel synthetic compounds have been available for decades as quasi-legal alternatives to controlled substances. The hallucinogen-like effects of eight novel substituted tryptamines were evaluated to determine their potential abuse liability. Male Sprague-Dawley rats were trained to discriminate 2,5-dimethoxy-4-methylamphetamine (DOM, 0.5 mg/kg, i.p., 30 min) from saline....

DOI: 10.1021/acsptsci.0c00173 (opens in new tab) Full text (opens in new tab) Tryptamines Stimulus control Hallucinogen Abuse liability +3

Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats

Journal of Psychopharmacology July 1, 2020 Michael B. Gatch, Michael J Forster

Background: Synthetic cathinone derivatives are used as alternatives both for stimulant drugs such as cocaine and methamphetamine and for club drugs such as 3,4-methylenedioxymethamphetamine (MDMA), but little is known about their MDMA-like subjective effects. Methods In order to determine their similarity to MDMA, the discriminative stimulus effects of 10 pyrrolidinyl cathinones...

Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats

Behavioural Pharmacology June 1, 2020 Michael B. Gatch, Sean B. Dolan, Michael J. Forster 6 citations

Synthetic cathinone derivatives are commonly considered quasi-legal alternatives for stimulant drugs, such as cocaine and methamphetamine, but some derivatives are increasingly being detected in club drug formulations of Ecstasy or ‘Molly’ as substitutes for methylenedioxymethamphetamine (±-MDMA). Although several studies have evaluated the psychostimulant-like effects of synthetic cathinones,...

Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis

Journal of Psychopharmacology June 18, 2018 Sean B. Dolan, Ritu A. Shetty, Michael J. Forster et al. 2 citations

BACKGROUND: Substituted piperazines comprise a substantial proportion of the novel psychoactive substance market. Among the most widely abused piperazine compounds are meta-chlorophenylpiperazine (mCPP), tri-fluoromethylphenylpiperazine (TFMPP), and, especially, benzylpiperazine (BZP), which are commonly incorporated, either alone or in combination, in illicit "party pills" or "ecstasy"...

Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of five novel synthetic cannabinoids in rats.

Psychopharmacology March 2018 Michael B. Gatch, Michael J Forster

Novel synthetic cannabinoid compounds continue to appear in the market advertised as legal alternatives to marijuana and the older synthetic cannabinoid compounds which are now controlled substances. Most of these newer compounds have been found to act at CB1 receptors, so the purpose of this study was to study the abuse liability of these compounds. Five of these compounds (BB-22, FUB-PB-22,...

DOI: 10.1007/s00213-017-4783-6 (opens in new tab) Full text (opens in new tab) Abuse liability Cannabinoids Drug discrimination Locomotor activity +2

“Ecstasy” to Addiction: Mechanisms and Reinforcing Effects of Three Synthetic Cathinone Analogs of MDMA

Neuropharmacology January 31, 2018 Sean B. Dolan, Zhenglan Chen, Renqi Huang et al.

ABSTRACT This study aimed to address the mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA commonly reported in “Ecstasy” formulations: methylone, butylone, and pentylone. Whole‐cell patch clamp techniques were used to assess the mechanism of each compound at the dopamine and serotonin transporters. Separate groups of rats were trained to discriminate...

Discriminative stimulus and locomotor effects of para-substituted and benzofuran analogs of amphetamine.

Drug and Alcohol Dependence November 1, 2017 Sean B. Dolan, Michael J Forster, Michael B. Gatch

Novel psychoactive substances have maintained a prominent role in the global drug culture, despite increased regulation by governing bodies. Novel compounds continue to become available on the market, often in "Ecstasy" or "Molly" formulations in lieu of MDMA, at a much faster rate than they can be properly characterized. The current study aimed to investigate the discriminative stimulus and...

Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Behavioural Pharmacology August 1, 2017 Michael B. Gatch, Sean B. Dolan, Michael J. Forster 36 citations

There has been increasing use of novel synthetic hallucinogenic compounds, 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25B-NBOMe), 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25C-NBOMe), 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine hydrochloride (25I-NBOMe), and N,N-diallyl-5-methoxy tryptamine (5-MeO-DALT),...

Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents.

Behavioural Pharmacology September 2016 Michael B. Gatch, Sean B. Dolan, Michael J Forster

5,6-Methylenedioxy-2-aminoindane (MDAI) has become a common substitute for (±)-3,4-methylenedioxymethamphetamine (MDMA) in Ecstasy. MDAI is known to produce MDMA-like discriminative stimulus effects, but it is not known whether MDAI has psychostimulant or hallucinogen-like effects. MDAI was tested for locomotor stimulant effects in mice and subsequently for discriminative stimulus effects in...

Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.

Psychopharmacology May 2016 Michael B. Gatch, Michael J Forster

Novel cannabinoid compounds continue to be marketed as "legal" marijuana substitutes, even though little is known about their molecular and behavioral effects. Six of these compounds (ADBICA, ADB-PINACA, THJ-2201, RCS-4, JWH-122, JWH-210) were tested for in vitro and in vivo cannabinoid-like effects to determine their abuse liability. Binding to and functional activity at CB1 cannabinoid...

DOI: 10.1007/s00213-016-4237-6 (opens in new tab) Full text (opens in new tab) Abuse liability Cannabinoids Drug discrimination Locomotor activity +2

Neuropharmacology of N,N-dimethyltryptamine

Brain Research Bulletin April 30, 2016 Theresa M. Carbonaro, Michael B. Gatch 258 citations

N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggests that endogenous DMT plays important roles for a number of processes in the periphery and central nervous system, and may act as a neurotransmitter. This paper reviews the current literature of both...

DOI: 10.1016/j.brainresbull.2016.04.016 (opens in new tab) Full text (opens in new tab) Neuropharmacology Central nervous system Neurotransmitter systems Adverse effect +6

Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.

Behavioural Pharmacology August 2015 Michael B. Gatch, Michael J Forster

When synthetic cannabinoid compounds became controlled by state and federal governments, different, noncontrolled compounds began to appear as marijuana substitutes. Unlike the scheduled cannabinoids, the newer compounds have not been characterized for potency and efficacy in preclinical studies. The purpose of these experiments was to determine whether some of the more recent synthetic...

Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.

Behavioural Pharmacology December 2014 Michael B. Gatch, Michael J Forster

A number of cannabinoid compounds are being sold in the form of incense as 'legal' alternatives to marijuana. The purpose of these experiments was to determine whether the most common of these compounds have discriminative stimulus effects similar to Δ-tetrahydrocannabinol (Δ-THC), the main active component in marijuana. Locomotor depressant effects of JWH-018, JWH-073, JWH-200, JWH-203,...

The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

Psychopharmacology July 2, 2014 Theresa M. Carbonaro, Amy J. Eshleman, Michael J. Forster et al. 67 citations

RationaleSerotonin 5-HT2A and 5-HT2C receptors are thought to be the primary pharmacological mechanisms for serotonin-mediated hallucinogenic drugs, but recently there has been interest in metabotropic glutamate (mGluR2) receptors as contributors to the mechanism of hallucinogens.ObjectiveThe present study assesses the role of these 5-HT and glutamate receptors as molecular targets for two...

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Psychopharmacology March 1, 2014 Amy J. Eshleman, Michael J Forster, Katherine M. Wolfrum et al. 72 citations

Psychoactive-substituted phenethylamines 2,5-dimethoxy-4-chlorophenethylamine (2C-C); 2,5-dimethoxy-4-methylphenethylamine (2C-D); 2,5-dimethoxy-4-ethylphenethylamine (2C-E); 2,5-dimethoxy-4-iodophenethylamine (2C-I); 2,5-dimethoxy-4-ethylthiophenethylamine (2C-T-2); and 2,5-dimethoxy-4-chloroamphetamine (DOC) are used recreationally and may have deleterious side effects. This study compares...

DOI: 10.1007/s00213-013-3303-6 (opens in new tab) Full text (opens in new tab) Phenethylamines Psychoactive compounds Drugs Substances +12

The HIV antiretroviral drug efavirenz has LSD-like properties.

Neuropsychopharmacology May 24, 2013 Michael B. Gatch, Alexey Kozlenkov, Ren-Qi Huang et al.

Anecdotal reports have surfaced concerning misuse of the HIV antiretroviral medication efavirenz ((4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one) by HIV patients and non-infected teens who crush the pills and smoke the powder for its psychoactive effects. Molecular profiling of the receptor pharmacology of efavirenz pinpointed interactions with...

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Psychopharmacology March 1, 2013 Theresa M. Carbonaro, Michael J Forster, Michael B. Gatch

Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the synthetic hallucinogen N,N-diisopropyltryptamine (DiPT) is known for its production of auditory distortions. This study compares the discriminative stimulus effects of DiPT to those of visual hallucinogens. Adult male rats were trained to...

Abuse Liability Profile of Three Substituted Tryptamines

Journal of Pharmacology and Experimental Therapeutics April 8, 2011 Michael B. Gatch, Michael J. Forster, Aaron Janowsky et al. 42 citations

The abuse liability profile of three synthetic hallucinogens, N,N-diisopropyltryptamine (DIPT), 5-N,N-diethyl-5-methoxytryptamine (5-MeO-DET), and 5-methoxy-α-methyltryptamine (5-MeO-AMT), was tested in rats trained to discriminate hallucinogenic and psychostimulant compounds, including cocaine, methamphetamine, 3,4-methylenedioxymethylamphetamine (MDMA), lysergic acid diethylamide (LSD),...

Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats

Psychopharmacology July 1, 2009 Michael B. Gatch, Margaret A. Rutledge, Theresa M. Carbonaro et al.

Rationale There has been increased recreational use of dimethyltryptamine (DMT), but little is known of its discriminative stimulus effects. Objectives The present study assessed the similarity of the discriminative stimulus effects of DMT to other types of hallucinogens and to psychostimulants. Methods Rats were trained to discriminate DMT from saline. To test the similarity of DMT to known...

DOI: 10.1007/s00213-009-1501-z (opens in new tab) Full text (opens in new tab) Drug discrimination Cross-substitution Hallucinogen Psychostimulant +5